(2S,4R)-1-((S)-2-(Tert-butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
![(2S,4R)-1-((S)-2-(Tert-butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide](https://ouhetech.com/wp-content/uploads/2026/06/A21571.png)
(2S,4R)-1-((S)-2-(Tert-butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Product Specifications
CAS Number:
1797406-69-9
MDL Number:
Product Code:
ID:
A21571
Purity:
98%
Packaging:
| Product Number | A21571 |
| Name | (2S,4R)-1-((S)-2-(Tert-butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
| CAS | 1797406-69-9 |
| MDL | |
| Purity | 98% |
| Concentration | |
| Packaging | |
| M.F | C49H60ClN9O8S2 |
| M.W | 1002.644 |
| Storage | Refrigerate, sealed |
| Appearance | |
| Melting Point | |
| Boiling Point | |
| Density | |
| Flash Point | |
| Water Solubility | |
| Evapouration rate | |
| Vapour pressure | |
| Vapor Density | |
| Decomposition temperature | |
| Viscosity | |
| Sensitivity | |
| Explosive properties | |
| Oxidizing properties | |
| Incompatibilities | |
| Odour | |
| Odour Threshold | |
| SMILES | |
| InChICode | |
| InChIKey |
| GHS Symble | |
| Warning Words | |
| H-Code | |
| P-Code | |
| EINECS | |
| Hazard Codes(Europe) | |
| EU_Hazard_Risk_Phrases | |
| EU_Hazard_Safety_Phrases | |
| UN Number | |
| Transport hazard class(es) | |
| Packaging group |
| Acute Toxicity | |
| Skin corrosion/irritation | |
| Serious eye Damage/irritation | |
| Respiratory or skin sensitisation | |
| Germ Cell mutagenicity | |
| Carcinogenicity | |
| Reproductive toxicity | |
| STOT-single exposure | |
| STOT-repeated exposure | |
| Aspiration hazard |
| Purpose |
![(S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide](https://ouhetech.com/wp-content/uploads/2026/06/A21713.png)
